Skip to main content
Top
Published in: BMC Geriatrics 1/2024

Open Access 01-12-2024 | Septicemia | Research

Effect of neutrophil to lymphocyte ratio on prognosis of elderly patients with severe sepsis combined with diabetes mellitus

Authors: Shan Jin, Jun-bin Yin, Wei Li, Li-li Zang

Published in: BMC Geriatrics | Issue 1/2024

Login to get access

Abstract

Background

To investigate the predictive value of neutrophil-to-lymphocyte ratio (NLR) in the short-term prognosis of elderly patients with severe sepsis combined with diabetes mellitus (DM).

Methods

The clinical data of 162 elderly patients with severe sepsis combined with DM from January 2018 to December 2022 were retrospectively collected. These patients were divided into a survival group (n = 104) and a death group (n = 58) according to 90-day prognosis. The number of neutrophils, lymphocytes, and NLR were compared. The optimal cut-off value for NLR to predict 90-day prognosis in elderly patients with severe sepsis combined with DM was determined using Receiver Operator Characteristic (ROC) curves, and the patients were divided into high and low NLR groups depending on the optimal cut-off value. The Kaplan-Meier method was used to plot the survival curves of the high and low NLR groups. Risk factors for the 90-day death in elderly patients with severe sepsis combined with DM were analyzed by a multivariate cox regression model.

Results

There were no significant differences in gender, age, history of hypertension and hyperlipidemia, intensive care unit (ICU) stay, duration of mechanical ventilation, and oxygenation index between the survival group and death group (p > 0.05). However, acute physiological and chronic health evaluation II (APACHE II) scores, and sepsis-related organ failure assessment (SOFA) scores were significantly lower in the survival group compared with the death group (p < 0.05). In the survival group, neutrophils counts and NLR were much lower than those in the death group, while lymphocytes counts were much higher (p < 0.05). ROC curves showed that the optimal cut-off value for NLR to predict 90-day mortality in elderly patients with severe sepsis combined with DM was 3.482. Patients were divided into high NLR and low NLR groups based on whether NLR was ≥ 3.482. In terms of the log-rank test results, patients in the low NLR group had a significantly higher 90-day survival rate than those in the high NLR group (Logrank χ2 = 8.635, p = 0.003). The multivariate cox regression model showed that the length of ICU stay longer than 15 days and NLR ≥ 3.482 were independent risk factors for 90-day prognosis in elderly patients with severe sepsis combined with DM.

Conclusion

NLR ≥ 3.482 can be used to predict whether poor prognosis occurs in the short term after illness in elderly patients with severe sepsis combined with DM, and has good assessment value.
Literature
3.
go back to reference Fleischmann-Struzek C, et al. Incidence and mortality of hospital- and ICU-treated sepsis: results from an updated and expanded systematic review and meta-analysis. Intensive Care Med. 2020;46(8):1552–62.CrossRefPubMedPubMedCentral Fleischmann-Struzek C, et al. Incidence and mortality of hospital- and ICU-treated sepsis: results from an updated and expanded systematic review and meta-analysis. Intensive Care Med. 2020;46(8):1552–62.CrossRefPubMedPubMedCentral
4.
go back to reference Qiu P, Liu Y, Zhang J. Review: the Role and mechanisms of Macrophage Autophagy in Sepsis. Inflammation. 2019;42(1):6–19.CrossRefPubMed Qiu P, Liu Y, Zhang J. Review: the Role and mechanisms of Macrophage Autophagy in Sepsis. Inflammation. 2019;42(1):6–19.CrossRefPubMed
5.
7.
go back to reference Buonacera A et al. Neutrophil to lymphocyte ratio: an emerging marker of the relationships between the Immune System and diseases. Int J Mol Sci, 2022. 23(7). Buonacera A et al. Neutrophil to lymphocyte ratio: an emerging marker of the relationships between the Immune System and diseases. Int J Mol Sci, 2022. 23(7).
9.
go back to reference Carey IM, et al. Risk of infection in type 1 and type 2 diabetes compared with the General Population: a matched cohort study. Diabetes Care. 2018;41(3):513–21.ADSCrossRefPubMed Carey IM, et al. Risk of infection in type 1 and type 2 diabetes compared with the General Population: a matched cohort study. Diabetes Care. 2018;41(3):513–21.ADSCrossRefPubMed
11.
go back to reference Frydrych LM, et al. Obesity and type 2 diabetes mellitus drive immune dysfunction, infection development, and sepsis mortality. J Leukoc Biol. 2018;104(3):525–34.CrossRefPubMed Frydrych LM, et al. Obesity and type 2 diabetes mellitus drive immune dysfunction, infection development, and sepsis mortality. J Leukoc Biol. 2018;104(3):525–34.CrossRefPubMed
13.
go back to reference Akinosoglou K, et al. Diabetes on sepsis outcomes in non-ICU patients: a cohort study and review of the literature. J Diabetes Complications. 2021;35(1):107765.CrossRefPubMed Akinosoglou K, et al. Diabetes on sepsis outcomes in non-ICU patients: a cohort study and review of the literature. J Diabetes Complications. 2021;35(1):107765.CrossRefPubMed
14.
go back to reference Liu C et al. SOFA Score in relation to Sepsis: Clinical Implications in Diagnosis, Treatment, and Prognostic Assessment Comput Math Methods Med, 2022. 2022: p. 7870434. Liu C et al. SOFA Score in relation to Sepsis: Clinical Implications in Diagnosis, Treatment, and Prognostic Assessment Comput Math Methods Med, 2022. 2022: p. 7870434.
15.
go back to reference Mayow AH, et al. A systematic review and Meta-analysis of Independent predictors for Acute respiratory distress syndrome in patients presenting with Sepsis. Cureus. 2023;15(4):e37055.PubMedPubMedCentral Mayow AH, et al. A systematic review and Meta-analysis of Independent predictors for Acute respiratory distress syndrome in patients presenting with Sepsis. Cureus. 2023;15(4):e37055.PubMedPubMedCentral
16.
go back to reference Spoto S et al. Diagnostic accuracy and Prognostic Value of Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in septic patients outside the Intensive Care Unit. Med (Kaunas), 2021. 57(8). Spoto S et al. Diagnostic accuracy and Prognostic Value of Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in septic patients outside the Intensive Care Unit. Med (Kaunas), 2021. 57(8).
17.
go back to reference Djordjevic D et al. Neutrophil-to-Lymphocyte Ratio, Monocyte-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Mean Platelet Volume-to-Platelet Count Ratio as Biomarkers in Critically Ill and Injured Patients: Which Ratio to Choose to Predict Outcome and Nature of Bacteremia? Mediators Inflamm, 2018. 2018: p. 3758068. Djordjevic D et al. Neutrophil-to-Lymphocyte Ratio, Monocyte-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Mean Platelet Volume-to-Platelet Count Ratio as Biomarkers in Critically Ill and Injured Patients: Which Ratio to Choose to Predict Outcome and Nature of Bacteremia? Mediators Inflamm, 2018. 2018: p. 3758068.
18.
19.
go back to reference Zahorec R. Neutrophil-to-lymphocyte ratio, past, present and future perspectives. Bratisl Lek Listy. 2021;122(7):474–88.PubMed Zahorec R. Neutrophil-to-lymphocyte ratio, past, present and future perspectives. Bratisl Lek Listy. 2021;122(7):474–88.PubMed
20.
go back to reference Sun B, et al. Clinical value of neutrophil-to-lymphocyte ratio and prognostic nutritional index on prediction of occurrence and development of diabetic foot-induced sepsis. Front Public Health. 2023;11:1181880.CrossRefPubMedPubMedCentral Sun B, et al. Clinical value of neutrophil-to-lymphocyte ratio and prognostic nutritional index on prediction of occurrence and development of diabetic foot-induced sepsis. Front Public Health. 2023;11:1181880.CrossRefPubMedPubMedCentral
22.
go back to reference Jiang J, et al. The neutrophil-lymphocyte count ratio as a diagnostic marker for bacteraemia: a systematic review and meta-analysis. Am J Emerg Med. 2019;37(8):1482–9.CrossRefPubMed Jiang J, et al. The neutrophil-lymphocyte count ratio as a diagnostic marker for bacteraemia: a systematic review and meta-analysis. Am J Emerg Med. 2019;37(8):1482–9.CrossRefPubMed
23.
go back to reference Huang Z, et al. Prognostic value of neutrophil-to-lymphocyte ratio in sepsis: a meta-analysis. Am J Emerg Med. 2020;38(3):641–7.CrossRefPubMed Huang Z, et al. Prognostic value of neutrophil-to-lymphocyte ratio in sepsis: a meta-analysis. Am J Emerg Med. 2020;38(3):641–7.CrossRefPubMed
24.
go back to reference Jackaman C, et al. Aging and cancer: the role of macrophages and neutrophils. Ageing Res Rev. 2017;36:105–16.CrossRefPubMed Jackaman C, et al. Aging and cancer: the role of macrophages and neutrophils. Ageing Res Rev. 2017;36:105–16.CrossRefPubMed
25.
go back to reference Tomay F, et al. Aged neutrophils accumulate in lymphoid tissues from healthy elderly mice and infiltrate T- and B-cell zones. Immunol Cell Biol. 2018;96(8):831–40.CrossRefPubMed Tomay F, et al. Aged neutrophils accumulate in lymphoid tissues from healthy elderly mice and infiltrate T- and B-cell zones. Immunol Cell Biol. 2018;96(8):831–40.CrossRefPubMed
26.
go back to reference Gauer JS, Ajjan RA, Ariens RAS. Platelet-Neutrophil Interaction and Thromboinflammation in Diabetes: considerations for Novel Therapeutic approaches. J Am Heart Assoc. 2022;11(20):e027071.CrossRefPubMedPubMedCentral Gauer JS, Ajjan RA, Ariens RAS. Platelet-Neutrophil Interaction and Thromboinflammation in Diabetes: considerations for Novel Therapeutic approaches. J Am Heart Assoc. 2022;11(20):e027071.CrossRefPubMedPubMedCentral
27.
28.
go back to reference Wan H, et al. Associations between the neutrophil-to-lymphocyte ratio and Diabetic complications in adults with diabetes: a cross-sectional study. J Diabetes Res. 2020;2020:p6219545.CrossRef Wan H, et al. Associations between the neutrophil-to-lymphocyte ratio and Diabetic complications in adults with diabetes: a cross-sectional study. J Diabetes Res. 2020;2020:p6219545.CrossRef
Metadata
Title
Effect of neutrophil to lymphocyte ratio on prognosis of elderly patients with severe sepsis combined with diabetes mellitus
Authors
Shan Jin
Jun-bin Yin
Wei Li
Li-li Zang
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Geriatrics / Issue 1/2024
Electronic ISSN: 1471-2318
DOI
https://doi.org/10.1186/s12877-024-04757-0

Other articles of this Issue 1/2024

BMC Geriatrics 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine